Curative Biotechnology Inc (CUBT)

[Wrangler1]

#4 post:

CUBT has an Exclusive Patent License Agreement to repurpose the use of Metformin, one of the most prescribed drugs in the world, to treat Retinal Degeneration (RD), one of the biggest causes of blindness in the elderly. The agreements are listed with the Federal Government’s National Eye Institute (NEI), an arm of the National Institutes of Health (NIH).

CUBT has also hired Dr. Kapil Bharti, the lead inventor on all of the licensed patents (pending) from NEI at NIH, onto its Scientific and Clinical Advisory Board to help guide the program. His expertise and insights will be invaluable. I don’t think he would be putting his reputation on the line if he was say, only a mantle piece.

This is kind of company I can get behind as they develop their product pipeline working in a financially responsible way without having a corporate office, which we all know costs money.